Senti Biosciences Holdings, Inc.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-046/4/26 | New | $10,000,000 | $10,000,000 | Debt Only | 06b | SEC linkSEC |
| 2024-12-1912/19/24 | New | $37,604,250 | $37,604,250 | Equity Only | 06b | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Bryan Baum | Director |
| James J. Collins | Director |
| Brenda Cooperstone | Director |
| Jay Cross | Executive |
| Feng Hsiung | Director |
| Yvonne Li | Executive |
| Timothy Lu | Director, Executive |
| Edward Mathers | Director |
| Kanya Rajangam | Executive |
| Frances D. Schulz | Director |
| Fran Schulz | Director |
| Donald Tang | Director |
Industry: Biotechnology (See others in industry)
Address:
2 Corporate Drive, First Floor
South San Francisco, CA, 94080
Phone: 650-239-2030
South San Francisco, CA, 94080
Phone: 650-239-2030